Company lists · Data refreshed September 2026
Top 18 Immunotherapy venture capital companies based in South San Francisco, United States
RevenueBase identified 28 immunotherapy venture capital companies headquartered in South San Francisco, United States as of September 2026 and tracks 2,179 professional contacts across them, including 980 with verified work emails. Cambridge is the largest hub.
This list covers immunotherapy venture capital companies headquartered in South San Francisco, United States, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, how directly it supports the match, and when it was last checked. Data refreshed September 3, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase SmartSearch, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 18 largest immunotherapy venture capital companies based in South San Francisco, United States
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | Lyell ImmunopharmaIndirect evidence | 212 | |||
“Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 2 | AlumisIndirect evidence | 124 | |||
“At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 3 | Rapt TherapeuticsIndirect evidence | 123 | |||
“RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 4 | Pionyr ImmunotherapeuticsPartial evidence | 67 | |||
“In 2015, Pionyr Immunotherapeutics embarked on a journey to forge a new path in immuno-oncology for patients in need.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 5 | 57 | ||||
“ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 6 | 31 | ||||
“3T is an immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad patient…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 7 | 29 | ||||
“Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 8 | 28 | ||||
“Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 9 | Link Cell TherapiesPartial evidence | 27 | |||
“Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with investors Samsara BioCapital and Sheatree Capital.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 10 | Tizona Therapeutics, INCIndirect evidence | 22 | |||
“Tizona Therapeutics, Inc, is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 11 | Pact PharmaIndirect evidence | 19 | |||
“At PACT Pharma, our vision is to create potentially curative T cell therapies for solid cancers that are tailored for each and every patient.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 12 | 15 | ||||
“At CERo, we are expanding the armamentarium of engineered cell therapies to create a whole new class of innovative medicines for oncology.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 13 | Qlsf Biotherapeutics, INCIndirect evidence | 12 | |||
“QLSF Biotherapeutics is an innovative immuno-oncology biotech startup in South San Francisco.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 14 | Harpoon TherapeuticsIndirect evidence | 11 | |||
“Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 15 | Tegmine Therapeutics, INCIndirect evidence | 7 | |||
“At Tegmine we target glycoproteins, which are a hallmark of numerous solid cancers and drive aggressive disease.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 16 | 7 | ||||
“IgGenix is a clinical-stage, venture backed biotechnology company founded on breakthrough advances in Steve Quake’s laboratory at Stanford in collaboration with allergy clinician…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 17 | Primevax Immuno-OncologyIndirect evidence | 4 | |||
“PrimeVax Immuno-Oncology, Inc.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 18 | 2 | ||||
“A clinical stage biotechnology company developing synthetic biology platform company developing a new technology for directly modulating cytokine signaling pathways in health and…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
Showing 18 of 28 immunotherapy venture capital companies based in South San Francisco, United States
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 980 reachable decision-makers.
Free signup · no credit card
Immunotherapy venture capital companies based in South San Francisco, United States at a glance
As of Sep 3, 2026Companies by employee count
Email recency for this list is measured across the whole United States list rather than this city, so it is reported there. Company counts and contact totals on this page are exact for South San Francisco, over 28 companies.
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among immunotherapy venture capital companies, so some rows will be adjacent to the category rather than pure plays. The description and evidence rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase SmartSearch, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in South San Francisco, United States whose own description of what they do matches “immunotherapy venture capital companies”. Matching reads each company's description, not its industry code or its name.
- What we exclude
- Companies whose own description does not clearly place them among immunotherapy venture capital companies, and records with no verified work email. Companies headquartered outside South San Francisco are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and an evidence rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 980 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 3, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Immunotherapy venture capital companies by metro in the United States
- Immunotherapy venture capital companies in Cambridge50
- Immunotherapy venture capital companies in San Diego49
- Immunotherapy venture capital companies in Boston39
- Immunotherapy venture capital companies in New York29
- Immunotherapy venture capital companies in South San Francisco28
- Immunotherapy venture capital companies in San Francisco26
Frequently asked
How many immunotherapy venture capital companies are there based in South San Francisco, United States?
RevenueBase identified 28 immunotherapy venture capital companies headquartered in South San Francisco, United States as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Lyell Immunopharma, headquartered in South San Francisco, tops this list with the largest team on record.
Which city has the most immunotherapy venture capital companies?
Cambridge leads with 50 headquartered companies, followed by San Diego (49) and Boston (39).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 980 verified decision-maker contacts tracked across these 28 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 3, 2026.
Ready to reach these companies? Verified emails and direct dials for all 28 immunotherapy venture capital companies based in South San Francisco, United States. Start with a free account, no credit card.
Get the full listRelated lists
Immunotherapy venture capital companies by geography
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in the United Kingdom
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia
- Immunotherapy venture capital companies based in Spain
- Immunotherapy venture capital companies based in Boston, United States
- Immunotherapy venture capital companies based in Cambridge, United States
- Immunotherapy venture capital companies based in New York, United States
- Immunotherapy venture capital companies based in San Diego, United States
Browse the directory
Browse: Companies home · Immunotherapy venture capital companies in United States · All United States lists · All Immunotherapy venture capital companies lists · New lists
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase SmartSearch, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in the United Kingdom
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland